Global Protein Sequencing Market

Protein Sequencing Market Size, Share, Growth Analysis, By Application(Biopharmaceuticals, biotechnology research), By Technology(Mass spectrometry, Edman degradation), By Region - Industry Forecast 2024-2031


Report ID: SQSG35H2025 | Region: Global | Published Date: July, 2036
Pages: 242 | Tables: 61 | Figures: 75

Protein Sequencing Market Competitive Landscape

Global Protein Sequencing Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Protein Sequencing Market Top Player's Company Profiles

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Waters Corporation
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Bio-Rad Laboratories, Inc.
  • Shimadzu Corporation
  • SCIEX (a subsidiary of Danaher Corporation)
  • GE Healthcare
  • Illumina, Inc.
  • Sartorius AG
  • AB Sciex Pte. Ltd. (a subsidiary of Danaher Corporation)
  • Bioinformatics Solutions Inc.
  • Genedata AG
  • Luminex Corporation
  • Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation)
  • Qiagen N.V.
  • Promega Corporation
  • Proteome Sciences plc.

Protein Sequencing Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Protein Sequencing Market size was valued at USD 1.3 billion in 2019 and is poised to grow from USD 1.34 billion in 2023 to USD 1.69 billion by 2031, growing at a CAGR of 3.5% in the forecast period (2024-2031).

Global Protein Sequencing Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Thermo Fisher Scientific Inc.', 'Danaher Corporation', 'Waters Corporation', 'Agilent Technologies, Inc.', 'PerkinElmer, Inc.', 'Bruker Corporation', 'Bio-Rad Laboratories, Inc.', 'Shimadzu Corporation', 'SCIEX (a subsidiary of Danaher Corporation)', 'GE Healthcare', 'Illumina, Inc.', 'Sartorius AG', 'AB Sciex Pte. Ltd. (a subsidiary of Danaher Corporation)', 'Bioinformatics Solutions Inc.', 'Genedata AG', 'Luminex Corporation', 'Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation)', 'Qiagen N.V.', 'Promega Corporation', 'Proteome Sciences plc.'

The factor projected to propel the expansion of the target market over the forecast period is improvements in clinical mass spectrometry and analytical procedures. In addition, growing financial support from the public and private sectors for proteome research is a key dynamic anticipated to fuel the development of the target market throughout the forecast period.

Protein engineering is the manipulation of protein structures to achieve desired properties or the synthesis of proteins with specific structures. Bioformulations, such as antibodies, nucleic acid products, and vaccines, account for the vast majority of therapeutic drugs on the market today. The incorporation of unnatural amino acids is a field in protein engineering that companies are focusing on for the site-specific conjugation of functional moieties to biopharmaceuticals (uAA). Rapid advances in post-translational engineering and strain development to produce better-defined products should result in faster biopharmaceutical approval.

North America held the largest global protein sequencing market share and is anticipated to continue dominating over the projection period. The target market in the region is anticipated to expand as a result of rising funding for proteome research from public and private organisations, as well as the presence of significant important players in nations like the US and Canada. In the upcoming years, it is predicted that the Asia Pacific market will represent a sizeable portion of the market's value. During the forecast period, China is anticipated to see the fastest growth rate. Rising government initiatives and investments in life science research and development in nations like India and Japan are anticipated to assist the expansion of the target market. Europe Protein Sequencing Market is predicted to experience moderate revenue growth over the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Protein Sequencing Market

Report ID: SQSG35H2025

$5,300
BUY NOW GET FREE SAMPLE